Community-acquired pneumonia is diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung
imaging, usually an infiltrate seen on chest radiography. Initial evaluation should determine the need for hospitalization versus outpatient management using validated mortality or severi...
Neumonía/diagnóstico por imagen,
Neumonía/terapia,
Enfermedades Respiratorias/diagnóstico,
Atención Ambulatoria/organización & administración,
Cultivo de Sangre/instrumentación,
Macrólidos/uso terapéutico,
Doxiciclina/uso terapéutico,
Antibacterianos/uso terapéutico,
Fluoroquinolonas/uso terapéutico,
Unidades de Cuidados Intensivos,
Neumonía Asociada a la Atención Médica/prevención & control
Intersecting epidemics Tuberculosis (TB) remains a considerable global public health concern, mainly affecting poor and vulnerable populations. Every year, more than 9 million people fall ill with this infectious disease, and close to 2 million die from it. Diabetes, a chronic metabolic disease that is i...
Since the beginning of the epidemic in the early 1980s, men who have sex with men (MSM) and transgender people have been disproportionately affected by the human immunodeficiency virus (HIV). The risk for infection remains high among them; and there has been a resurgence of HIV infection among MSM, parti...
Increasing access to antiretroviral therapy (ART) has transformed the prognosis of HIVinfected patients in resource-limited settings (RLS). However, treatment coverage remains relatively low, and HIV diagnosis occurs at a late stage. As a result, many patients continue to die of HIV-related opportunistic...
Criptococosis/diagnóstico,
Flucitosina/administración & dosificación,
Antifúngicos/administración & dosificación,
Infecciones Oportunistas Relacionadas con el SIDA/microbiología,
Fluconazol/administración & dosificación,
Anfotericina B/administración & dosificación,
Criptococosis,
Criptococosis/tratamiento farmacológico,
Criptococosis/prevención & control,
Meningitis Criptocócica/tratamiento farmacológico,
Quimioterapia Combinada
This 2011 update of Guidelines for the programmatic management of drug-resistant
tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of
multidrug-resistant tuberculosis and extensi...
Commercial liquid culture systems and molecular line-probe assays have been endorsed by the World Health Organization (WHO) as gold standards for rapid detection of multidrug-resistant (MDR) tuberculosis (TB); however, because of technical complexity, cost and the requirement for sophisticated laboratory...
Research over the past decade has resulted in the development of two commercial interferongamma release assays (IGRAs), based on the principle that the T-cells of individuals who have acquired TB infection respond to re-stimulation with Mycobacterium tuberculosis-specific antigens by secreting interferon...
Earlier and improved tuberculosis (TB) case detection - including smear-negative disease, often associated with HIV co-infection - as well as expanded capacity to diagnose multidrug-resistant tuberculosis (MDR-TB) are global priorities for TB control. Conventional laboratory methods are slow and cumberso...
Direct sputum smear microscopy is the most widely used means for the diagnosis of pulmonary tuberculosis (TB) and is available in most primary health-care laboratories at health-centre level. Smear microscopy may, however, be costly and inconvenient for patients, who have to make multiple visits to healt...
